January 27, 2020

Natera, Inc. v. ArcherDX, Inc.

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. December 01, 2023

    Natera Wins Cancer Test Injunction After $19M IP Verdict

    A Delaware federal judge has barred Invitae Corp. from using its Personalized Cancer Monitoring test in certain ways that infringe patents owned by Natera Inc., according to a rare injunction made public Friday.

5 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS